Crossref
FDA facing challenges: GAO
The Brown University Child & Adolescent Psychopharmacology Update · 2026-03 · 28 (3) · 7-8
DOI: 10.1002/cpu.31049 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Child & Adolescent Psychopharmacology Update, online erschienen am 11.03.2026.
Abstract (Originalsprache)
Last month the Government Accountability Office (GAO) released a report highlighting problems faced by the Food and Drug Administration (FDA) due to funding and staffing and operational challenges over the past decade.
Zitieren
APA
(2026). FDA facing challenges: GAO. The Brown University Child & Adolescent Psychopharmacology Update, 28(3), 7-8. https://doi.org/10.1002/cpu.31049
Vancouver
FDA facing challenges: GAO. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(3):7-8. doi:10.1002/cpu.31049
BibTeX
@article{euvimed2026,
title = {FDA facing challenges: GAO},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {3},
pages = {7--8},
doi = {10.1002/cpu.31049}
}
EUVIMED